Psychiatric comedication in patients with epilepsy

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Pharmacology

Background:

• Epilepsy patients exhibit higher rates of psychiatric disorders compared to the general population.
• Co-occurring psychiatric conditions necessitate pharmacotherapy, often involving psychotropic medications.

Purpose of the Study:

• To determine the frequency and types of psychotropic drug use in epilepsy patients.
• To identify risk factors associated with psychotropic drug prescription in this population.
• To evaluate the proconvulsive potential and drug interaction risks between psychotropic and antiepileptic drugs.

Main Methods:

• A prospective study over 20 months at a university hospital outpatient clinic.
• Classification of psychotropic drugs using the Anatomical Therapeutic Chemical Classification System.
• Logistic regression analysis to identify independent variables associated with psychotropic drug use.

Main Results:

• 14.3% of 621 epilepsy patients received psychiatric comedication, with sertraline, perazine, and hydroxyzine being most common.
• Factors associated with psychotropic use included age, active epilepsy, combined epilepsy types, somatic comedication, and phenobarbital.
• Over one-third of patients used both antiepileptic and psychotropic drugs, with 10% using psychotropics that may lower seizure threshold, posing interaction risks.

Conclusions:

• Significant psychotropic drug use occurs in epilepsy patients, necessitating careful consideration of interactions and proconvulsive potential.
• The findings underscore the importance of collaborative care between neurologists and psychiatrists for optimal patient management.
• Further research into safer psychotropic options and management strategies for epilepsy patients with psychiatric comorbidities is warranted.